Compare Medpace Holdings Inc (MEDP) vs Invesco S&P 500 Momentum ETF (SPMO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Invesco S&P 500 Momentum ETF — how do they compare? Medpace Holdings Inc trades at $530 (market cap $15.08B), while Invesco S&P 500 Momentum ETF trades at $150.08. Which is the better fit depends on your goals.
| MEDP | SPMO | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $620.59 | $161.66 |
52-Week Low | $308.88 | $107.84 |
Enterprise Value | $14.55B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Invesco S&P 500 Momentum ETF
SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →
